Notes
J ournal of Medicinal Chemistry, 1997, Vol. 40, No. 7 1167
1
layer was washed with water and brine, dried (Na2SO4), and
concentrated to dryness to give 4-phenylcubyl iodide (3.06 g,
100%) as a light yellow solid which was used in the next step
°C dec; H-NMR (D2O) 3.10 (s, 2 H) 3.75 (m, 3 H), 3.88 (m,
3 H) ppm; 13C-NMR (D2O) 41.1, 43.3, 47.4, 55.2, 60.1, 124.6,
126.2, 128.8, 142.9 ppm. Anal. (C15H16ClN) C, H, Cl, N.
1
without further purification: mp 77-79 °C; H-NMR 4.32
(4-Cyclopr opylcu byl)car bin ylam in e Hydr och lor ide Salt
(1b‚HCl). This compound was synthesized in a 78% yield in
the same way as was 1c‚HCl described above: mp 230 °C dec;
1H NMR (CD3OD) 0.18-0.43 (m, 4 H), 1.02 (m, 1 H), 3.13 (s,
2 H), 3.58 (m, 3 H), 3.77 (m, 3 H); 13C-NMR (CD3OD) 0.3,
12.8, 42.6, 44.6, 45.1, 57.1, 62.2 ppm. Anal. (C12H16NCl) C,
H, Cl, N.
(s, 6 H), 7.09-7.19 (m, 5 H) ppm; 13C-NMR 39.0, 52.0, 54.3,
60.5, 124.7, 126.3, 128.5, 141.5 ppm.
4-P h en ylcu ba n eca r boxylic Acid (4c). A solution of
4-phenylcubyl iodide (3.06 g, 0.01 mol) in dry THF (160 mL)
was cooled to -78 °C. tert-Butyllithium in pentane (1.7 M,
11.8 mL, 20 mmol) was added dropwise, and the resulting pale
yellow solution was stirred at -78 °C for 30 min. Dry CO2
was bubbled through for 10 min, and the reaction mixture was
allowed to warm up to room temperature while CO2 passed
through for 1 h. The reaction mixture was mixed with 50 mL
of aqueous HCl (2 M) and was extracted with chloroform. The
combined organic solution was washed with aqueous HCl (2
M) and dried over Na2SO4. Removal of the solvents gave
4-phenylcubanecarboxylic acid as a colorless solid in 71%
Cu bylca r bin yla m in e Hyd r och lor id e (1a ‚HCl). This
was synthesized in an 81% yield from the corresponding amide
in the same way as was 1c‚HCl: mp 275 °C dec; 1H-NMR (D2O)
3.00 (s, 2 H) 3.73 (m, 6 H), 3.82 (m, 1 H) ppm; 13C-NMR
(D2O) 41.1, 43.8, 46.6, 48.2, 54.0 ppm. Anal. (C9H12ClN) C,
H, Cl, N.
En zym e a n d Assa ys. Mitochondrial MAO (EC 1.4.3.4) was
isolated15 as previously reported. MAO was assayed by a
modification of the procedure of Tabor et al.16 A typical assay
would be the addition of a solution of MAO (5 L) to 0.495 mL
of a 2 mM benzylamine solution in 20 mM Tris‚HCl buffer,
pH 9.0 at 25 °C. The change in absorbance at 250 nm was
observed with time.
1
yield: mp 178-179 °C; H-NMR 4.19 (m, 3 H), 4.30 (m, 3
H), two sets of multiple peaks centered at 7.22 and 7.37 (5 H)
ppm; 13C-NMR 46.1, 48.7, 56.1, 60.2, 124.7, 126.2, 128.5,
141.8, 178.3 ppm.
4-Cyclop r op ylcu ba n eca r boxylic Acid (4b). The same
procedure was used as described for 4c except substituting
4-cyclopropylcubyl iodide.9 Recrystallization of the crude
product in hexane gave pure 4-cyclopropylcubanecarboxylic
acid as colorless plates in 62% yield: mp 155-156 °C; 1H-NMR
(CDCl3) 0.18 and 0.43 (m, 4 H), 1.00 (m, 1 H), 3.65 (m, 3 H),
4.08 (m, 3 H); 13C-NMR (CDCl3) 0.1, 11.7, 45.0, 45.8, 56.3,
60.4, 178.1 ppm. Anal. (C12H12O2) H; C: calcd, 76.57; found,
76.12.
Su bstr a te Activity of th e Cu bylca r bin yla m in e Hyd r o-
ch lor id es. Kinetic constants (Km and kcat) were determined
by measuring the amount of hydrogen peroxide that was
formed with time as described previously.17
Tim e-Dep en d en t In a ctiva tion Exp er im en ts (Gen er a l
Meth od s). Solutions (200 L each) of cubylcarbinylamine
hydrochlorides of various concentrations in 100 mM Tris
buffer, pH 9.0 containing 4% v/v DMSO (freshly distilled), were
preincubated at 25 °C. To these solutions was added MAO B
(20 L of 2.6 mg/mL). After being mixed, the samples were
incubated at 25 °C, periodically agitated, and assayed for MAO
activity by removing 10 L of the mixture and adding it to
490 L of a 1.0 mM benzylamine solution in 100 mM Tris
buffer, pH 9.0. The enzyme activity thus determined was
corrected against a control containing no inactivator (control
activity set to 100%). Kinetic constants (KI and kinact) were
determined as described by Kitz and Wilson.11 The control
enzyme also contained 4% DMSO (it was shown that there
are no adverse effects on activity up to 10% DMSO). After
inactivation each enzyme solution was dialyzed against 100
mM Tris-HCl buffer, pH 9.0, for 48 h to determine reversibility.
Gen er a l P r oced u r e for th e Syn th esis of Cu ba n eca r -
boxa m id es (5a -c). The cubanecarboxylic acid was dissolved
in oxalyl chloride (ca. 10 mL/g) and was stirred at room
temperature for 20 min. The excess oxalyl chloride was
removed under vacuum. The residue was dissolved in dry CH2-
Cl2 (ca. 40 mL/g) in a round bottom flask equipped with a cold
finger filled with dry ice/acetone, and NH3 gas was condensed
into the flask. After being stirred for 20 min, the resulting
suspension was allowed to warm to room temperature, and
the excess NH3 was slowly evaporated. The reaction mixture
was mixed with water and extracted with CHCl3, and the
combined organic solution was dried over Na2SO4. Removal
of solvents gave the cubanecarboxamides as white solids.
1
5a (89% yield): mp 209-212 °C; H NMR 4.01 (m, 4 H),
4.22 (m, 3 H), 5.41 (br, 2 H) ppm; 13C-NMR 44.8, 47.9, 49.5,
57.1, 174.9 ppm.
Effects of â-Mer ca p toeth a n ol a n d 2-P h en yleth yla m in e
on th e Ra te of In a ctiva tion of MAO B by Cu bylca r bin yl-
5b (96% yield): mp 225 °C dec. The crude product was used
for the next step without purification. The sample for elemen-
tal analysis was obtained by recrystallization of the crude
product in EtOAc and CHCl3: 1H-NMR (CDCl3) 0.18 and
0.43 (m, 4 H), 1.02 (m, 1 H), 3.63 (m, 3 H), 4.00 (m, 3 H), 5.40
(br 2 H); 13C-NMR (DMSO-d6) 0.0, 11.7, 43.6, 44.8, 57.7, 59.2,
173.3 ppm. Anal. (C12H13ON) H, N; C: calcd, 76.98; found,
76.38.
a m in es Hyd r och lor id e. The following solutions (200
L
each) were prepared in 100 mM Tris buffer, pH 9.0, containing
4% v/v DMSO and were preincubated at 25 °C: (1) (4-
phenylcubyl)carbinylamine hydrochloride (0.16 mM); (2) (4-
phenylcubyl)carbinylamine hydrochloride (0.16 mM) and -mer-
captoethanol (2 mM); (3) (4-cyclopropylcubyl)carbinylamine
hydrochloride (0.22 mM); (4) (4-cyclopropylcubyl)carbinylamine
hydrochloride (0.22 mM) and -mercaptoethanol (2 mM); and
(4) a control with only the buffer. To these solutions was added
MAO B (20 L of 2.6 mg/mL). The mixtures were incubated
at 25 °C, and MAO activity was assayed as described above.
The same experiments were repeated except the 2 mM
-mercaptoethanol was replaced with 2.4 mM 2-phenylethyl-
amine.
1
5c (80% yield): mp 196-197 °C; H-NMR 4.17 (m, 3 H),
4.22 (m, 3 H), 7.21-7.36 (5 H), 5.45 (br, 2 H) ppm; 13C-NMR
46.1, 48.3, 57.9, 60.3, 124.7, 126.2, 128.5, 141.9, 174.4 ppm.
(4-P h en ylcu byl)car bin ylam in e Hydr och lor ide Salt (1c‚-
HCl). The procedure described below was used also for 1a
and 1b. LiAlH4 (0.64 g, 11 mmol) was added slowly to a
suspension of 4-phenylcubanecarboxamide (0.81 g, 3.6 mmol)
in THF (80 mL) at 0 °C. The mixture was heated to reflux for
15 h and then it was cooled to room temperature. The excess
LiAlH4 was destroyed at 0 °C by dropwise addition of aqueous
NaOH (saturated), and then the mixture was stirred at room
temperature for 1 h. The granular precipitate was filtered off
and was washed with CH2Cl2, and the filtrate was dried (Na2-
SO4). Evaporation of the solvents gave (4-phenylcubyl)-
carbinylamine as a pale yellow oil (0.62 g, 82%): 1H-NMR
2.93 (s, 2 H) 3.81 (m, 3 H), 4.02 (m, 3 H), 7.21-7.35 (m, 5 H)
ppm. The oil was dissolved in dry ether (50 mL), and HCl
gas was bubbled through the solution. The resulting precipi-
tate was collected by filtration and was recrystallized from
methanol to give 0.5 g (69%) of (4-phenylcubyl)carbinylamine
hydrochloride salt (1c‚HCl) as colorless crystals: mp 203-204
Ack n ow led gm en t. The authors are grateful to the
National Institutes of Health (GM32634 to R.B.S.) and
to the National Science Foundation (CHE-9313413 to
P.E.) for financial support of this research.
Refer en ces
(1) Strolin Benedetti, M.; Dostert, P. Monoamine Oxidase: From
Physiology and Pathophysiology to the Design and Clinical
Application of reversible Inhibitors. Adv. Drug Res. 1992, 23,
65-125.
(2) J ohnston, J . P. Some Observations upon a New Inhibitor of
Monoamine Oxidase in Brain Tissue. Biochem. Pharmacol.
1968, 17, 1285-1297.